Taisho Pharmaceutical Holdings Co (TSE:4581) Other Long-Term Liabilities : 円50,258 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Other Long-Term Liabilities?

Taisho Pharmaceutical Holdings Co's other long-term liabilities for the quarter that ended in Dec. 2023 was 円50,258 Mil.

Taisho Pharmaceutical Holdings Co's quarterly other long-term liabilities increased from Jun. 2023 (円42,664 Mil) to Sep. 2023 (円47,217 Mil) and increased from Sep. 2023 (円47,217 Mil) to Dec. 2023 (円50,258 Mil).

Taisho Pharmaceutical Holdings Co's annual other long-term liabilities declined from Mar. 2021 (円38,588 Mil) to Mar. 2022 (円35,627 Mil) but then increased from Mar. 2022 (円35,627 Mil) to Mar. 2023 (円38,501 Mil).

Taisho Pharmaceutical Holdings Co Other Long-Term Liabilities Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Other Long-Term Liabilities Chart

Taisho Pharmaceutical Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Taisho Pharmaceutical Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Taisho Pharmaceutical Holdings Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Taisho Pharmaceutical Holdings Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

TAIPY:USA TAISF:USA

Address

3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655

Website

http://www.taisho-holdings.co.jp

Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines